Literature DB >> 10330429

Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development.

B Rocca1, L M Spain, E Puré, R Langenbach, C Patrono, G A FitzGerald.   

Abstract

Prostaglandin G and H synthases, or cyclooxygenases (COXs), catalyze the formation of prostaglandins (PGs). Whereas COX-1 is diffusely expressed in lymphoid cells in embryonic day 15.5 thymus, COX-2 expression is sparse, apparently limited to stromal cells. By contrast, COX-2 is predominant in a subset of medullary stromal cells in three- to five-week-old mice. The isozymes also differ in their contributions to lymphocyte development. Thus, experiments with selective COX-1 inhibitors in thymic lobes from normal and recombinase-activating gene-1 knockout mice support a role for this isoform in the transition from CD4(-)CD8(-) double-negative (DN) to CD4(+)CD8(+) double-positive (DP). Concordant data were obtained in COX-1 knockouts. Pharmacological inhibition and genetic deletion of COX-2, by contrast, support its role during early thymocyte proliferation and differentiation and, later, during maturation of the CD4 helper T-cell lineage. PGE2, but not other PGs, can rescue the effects of inhibition of either isoform, although it acts through distinct EP receptor subtypes. COX-dependent PG generation may represent a mechanism of thymic stromal support for T-cell development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330429      PMCID: PMC408457          DOI: 10.1172/JCI6400

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Localization of thromboxane synthase in human tissues by monoclonal antibody Tü 300.

Authors:  R Nüsing; G Sauter; P Fehr; U Dürmüller; M Kasper; F Gudat; V Ullrich
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 2.  T-cell differentiation in thymus organ cultures.

Authors:  E J Jenkinson; J J Owen
Journal:  Semin Immunol       Date:  1990-01       Impact factor: 11.130

3.  Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis.

Authors:  T Wang; J R Sheppard; J E Foker
Journal:  Science       Date:  1978-07-14       Impact factor: 47.728

4.  Expression of prostaglandin G/H synthase (cyclooxygenase) during murine fetal thymic development.

Authors:  P M Appasamy; K Pendino; R R Schmidt; K P Chepenik; M B Prystowsky; D Goldowitz
Journal:  Cell Immunol       Date:  1991-10-15       Impact factor: 4.868

5.  Thymocytes stimulate metabolism of arachidonic acid in rat thymic epithelial cells.

Authors:  L Sun; A S Piltch; P S Liu; L A Johnson; J Hayashi
Journal:  Cell Immunol       Date:  1990-11       Impact factor: 4.868

6.  Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.

Authors:  M Betz; B S Fox
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

7.  RAG-1-deficient mice have no mature B and T lymphocytes.

Authors:  P Mombaerts; J Iacomini; R S Johnson; K Herrup; S Tonegawa; V E Papaioannou
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

8.  Differential expression and regulation of cyclooxygenase isozymes in thymic stromal cells.

Authors:  B Rocca; L M Spain; G Ciabattoni; C Patrono; G A FitzGerald
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

9.  Production of prostaglandin E2 and prostacyclin by thymic nurse cells in culture.

Authors:  J E McCormack; J Kappler; P Marrack; J Y Westcott
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

10.  Interference with tolerance induction in vivo by inhibitors of prostaglandin synthesis.

Authors:  W V Scheuer; M V Hobbs; W O Weigle
Journal:  Cell Immunol       Date:  1987-02       Impact factor: 4.868

View more
  29 in total

Review 1.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.

Authors:  S L Tilley; T M Coffman; B H Koller
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Genetic and pharmacological analysis of prostanoid receptor function.

Authors:  S Narumiya; G A FitzGerald
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 3.  Why there are two cyclooxygenase isozymes.

Authors:  W L Smith; R Langenbach
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 4.  Regulated formation of eicosanoids.

Authors:  F A Fitzpatrick; R Soberman
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

5.  Not a mouse stirring: deletion of the EP2 and love's labor's lost.

Authors:  S Austin; G A FitzGerald
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

6.  Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17.

Authors:  Victoria A Blaho; Matthew W Buczynski; Edward A Dennis; Charles R Brown
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

7.  Targeted deletions of cyclooxygenase-2 and atherogenesis in mice.

Authors:  Yiqun Hui; Emanuela Ricciotti; Irene Crichton; Zhou Yu; Dairong Wang; Jane Stubbe; Miao Wang; Ellen Puré; Garret A FitzGerald
Journal:  Circulation       Date:  2010-06-07       Impact factor: 29.690

Review 8.  Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology.

Authors:  Hedi Harizi
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

9.  Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping.

Authors:  Meiping Chang; Sarah Smith; Andrew Thorpe; Michael J Barratt; Farzana Karim
Journal:  Mol Pain       Date:  2010-09-16       Impact factor: 3.395

10.  Cyclooxygenase-2 inhibits T helper cell type 9 differentiation during allergic lung inflammation via down-regulation of IL-17RB.

Authors:  Hong Li; Matthew L Edin; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Artiom Gruzdev; Jennifer Cheng; Ryan T Dackor; Ping Ming Wang; Carl D Bortner; Stavros Garantziotis; Anton M Jetten; Darryl C Zeldin
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.